Inicio › Cáncer del colon y del recto › Misuri

Ensayos clínicos de Cáncer del colon y del recto en Misuri

58 estudios sobre Cáncer del colon y del recto buscan participantes en Misuri.

Ciudades en Misuri

Texto oficial del estudio (inglés)

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia
Parkland Health Center - Farmington, Farmington
Heartland Regional Medical Center, Saint Joseph
y 6 más

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT05673148

Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

Washington University School of Medicine, St Louis

Reclutando

Edades de 65 a 82 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05612347

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

Saint Lukes Hospital of Kansas City /ID# 279513, Kansas City

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT07525206

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Washington University Medicine, St Louis

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06270706

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
Central Care Cancer Center - Bolivar, Bolivar
Cox Cancer Center Branson, Branson
y 21 más

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069

Family Communications After Genetic Testing

Mercy Oncology and Hematology - Clayton-Clarkson, Ballwin
Central Care Cancer Center - Bolivar, Bolivar
Cox Cancer Center Branson, Branson
y 18 más

ReclutandoSe aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT07143487

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

St. Lukes Hospital of Kansas City, Kansas City
Washington University School of Medicine, St Louis

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06625775

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

Washington University, St Louis

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07659795

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

Saint Lukes Hospital of Kansas City /ID# 270633, Kansas City

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT06820463

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Research Site, St Louis

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06218914

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Washington University, St Louis

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT04981119

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Washington University School Of Medicine, St Louis

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06750094

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Washington University School Of Medicine, St Louis

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06662786

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Local Institution - 0318, Kansas City
Washington University School OF Medicine-Siteman Cancer Center, St Louis

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT07221357

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Washington University, St Louis

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Washington University School of Medicine in St. Louis, St Louis

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07213791

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Washington University, St Louis

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT05786924

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Missouri Cancer Associates, Columbia
Saint Luke'S Hospital of Kansas City, Kansas City
Midamerica Cancer Care, Kansas City
y 2 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 sept 2026 · NCT07284849

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

Washington University School of Medicine, St Louis

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 11 sept 2026 · NCT05630794

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

Missouri Cancer Associates - 150518964, Columbia

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07549412

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Washington University School of Medicine, St Louis

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT06440005

Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer

Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
Siteman Cancer Center at West County Hospital, Creve Coeur
Washington University School of Medicine, St Louis
y 2 más

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT06696768

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Clinical Study Site, Springfield

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT07228832

The Vanguard Study: Testing a New Way to Screen for Cancer

Saint Luke's Hospital of Kansas City, Kansas City
Washington University School of Medicine, St Louis

ReclutandoSe aceptan voluntarios sanos

Edades de 45 a 75 · Todos los sexos · Actualizado el 2 sept 2026 · NCT06995898

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Washington University School of Medicine, St Louis

ReclutandoFase 1/2

12 Months – 30 Years · Todos los sexos · Actualizado el 25 ago 2026 · NCT04851119

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Washington University School of Medicine, St Louis

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 ago 2026 · NCT05919264

IDOV-Immune for Advanced Solid Tumors

Washington University School of Medicine, St Louis

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT06910657

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

University of Kansas Cancer Center - North, Kansas City
University of Kansas Cancer Center - Lee's Summit, Lee's Summit

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 31 jul 2026 · NCT05691491

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

Siteman Cancer Center - Washington University, St Louis

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 jul 2026 · NCT07094113

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Washington University, St Louis

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 jul 2026 · NCT04657068

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Washington University School of Medicine at St Louis, St Louis

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 jul 2026 · NCT03526835

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Investigative Site #110, St Louis

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 23 jul 2026 · NCT06974110

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

MidAmerica Cancer Care, Kansas City

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 jul 2026 · NCT06131840

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

Washington University School of Medicine, St Louis

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 14 jul 2026 · NCT06340646

CARE Tool Study Aim 3

Delbert Day Cancer Institute at Phelps Health, Rolla
Washington University School of Medicine, St Louis

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 8 jul 2026 · NCT07296887

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

Midwest Oncology Associates - Kansas City, Kansas City
SSM Health St. Louis DePaul Hospital, St Louis
Washington University School of Medicine, St Louis

ReclutandoFase 4

Edades de 18 en adelante · Todos los sexos · Actualizado el 7 jul 2026 · NCT06562543

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Saint Louis University, St Louis

ReclutandoFase 1/2

Edades de 18 a 90 · Todos los sexos · Actualizado el 6 jul 2026 · NCT06710756

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

Mercy Hospital - SPG, Springfield
Mercy Hospital - South, St Louis
Mercy Hospital -STL, St Louis

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 jun 2026 · NCT07327489

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Washington University, St Louis

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT06051695

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

Missouri Cancer Associates, Columbia

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 12 jun 2026 · NCT07011576

De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.